Literature DB >> 15942693

Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cells after irradiation and increase resistance to subsequent irradiation.

Jürgen Brieger1, Petra Schroeder, Jan Gosepath, Wolf J Mann.   

Abstract

We analysed the release of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) from squamous cell carcinoma (SCC) after irradiation and their potential contribution to radiation resistance. Three SCC cell lines were irradiated, and VEGF- and bFGF-release was quantified by Elisa-assay. Conditioned media (CM) were used in clonogenic assays for analysis of tumor cell survival. To evaluate the effect of tumor released VEGF and bFGF on survival, experiments with neutralizing monoclonal anti-VEGF and anti-bFGF antibodies were conducted in parallel. Cell cultures were irradiated with 2 Gy to analyse the effects of CM on tumor cell escape from radiation-induced death. We observed a marked increase in VEGF- and bFGF-release after irradiation by the surviving cells. Using these conditioned media, subsequently we observed an up to 10-fold increase in colony formation. The addition of anti-VEGF- and anti-bFGF-antibodies reduced colony formation, indicating that irradiation stimulates the release of growth promoting substances including VEGF and bFGF by the surviving cells. Additionally, irradiation of cells cultured with CM decreased colony formation about 50%, however, it was still increased 5-fold compared to the cultures without CM. The addition of VEGF- and/or bFGF-antibodies led to an additional 20% reduction of this radioprotective effect of the CM. This means, bFGF and VEGF contribute to a significant proportion of the survival stimulating activity. We thus show that irradiation might result in autologous protection of tumor cells from irradiation-induced cell death by the release of growth factors. These observations suggest that radiation might lead to unsuspected and undesired effects in tumorous tissue with possible clinical impact.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942693

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.

Authors:  Huita Wu; Jie Deng; Shiying Yu; Xin Wang; Yuan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

2.  Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells.

Authors:  Unmesh Jadhav; Sanjeeva Mohanam
Journal:  Int J Oncol       Date:  2006-12       Impact factor: 5.650

3.  Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line.

Authors:  Erian H Girgis; John P Mahoney; Rafaat H Khalil; Magdi R Soliman
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

4.  Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.

Authors:  Kerrington R Molhoek; Heinrich Griesemann; Jianfen Shu; Jeffrey E Gershenwald; David L Brautigan; Craig L Slingluff
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

5.  Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma.

Authors:  Amy M Buckley; Niamh Lynam-Lennon; Susan A Kennedy; Margaret R Dunne; John J Aird; Emma K Foley; Niamh Clarke; Narayanasamy Ravi; Dermot O'Toole; John V Reynolds; Breandán N Kennedy; Jacintha O'Sullivan
Journal:  Oncotarget       Date:  2018-09-14

Review 6.  FGF/FGFR signaling pathway involved resistance in various cancer types.

Authors:  Yangyang Zhou; Chengyu Wu; Guangrong Lu; Zijing Hu; Qiuxiang Chen; Xiaojing Du
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

7.  The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thromboembolism.

Authors:  Yuting Wang; Zegao Zhang; Pengcai Tao; Maimaitiyimin Reyila; Xiaoli Qi; Jie Yang
Journal:  Biomed Res Int       Date:  2020-08-08       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.